These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 9477644

  • 1. [Use of metformin in the management of adolescents with polycystic ovary syndrome].
    Zárate A, Hernández M, Fonseca ME, Ochoa R.
    Ginecol Obstet Mex; 1997 Dec; 65():504-7. PubMed ID: 9477644
    [Abstract] [Full Text] [Related]

  • 2. Metformin therapy increases insulin-like growth factor binding protein-1 in hyperinsulinemic women with polycystic ovary syndrome.
    Pawelczyk L, Spaczynski RZ, Banaszewska B, Duleba AJ.
    Eur J Obstet Gynecol Reprod Biol; 2004 Apr 15; 113(2):209-13. PubMed ID: 15063962
    [Abstract] [Full Text] [Related]

  • 3. Clinical and endocrinological effects of 6 months of metformin treatment in young hyperinsulinemic patients affected by polycystic ovary syndrome.
    Loverro G, Lorusso F, De Pergola G, Nicolardi V, Mei L, Selvaggi L.
    Gynecol Endocrinol; 2002 Jun 15; 16(3):217-24. PubMed ID: 12192894
    [Abstract] [Full Text] [Related]

  • 4. Clinical, metabolic and endocrine parameters in response to metformin in obese women with polycystic ovary syndrome: a randomized, double-blind and placebo-controlled trial.
    Chou KH, von Eye Corleta H, Capp E, Spritzer PM.
    Horm Metab Res; 2003 Feb 15; 35(2):86-91. PubMed ID: 12734787
    [Abstract] [Full Text] [Related]

  • 5. [Effects of metformin on the plasminogen activator system, endocrine, metabolic profiles in patients with polycystic ovary syndrome and clomiphene resistant cases].
    Song J, Shen H, Li J, Huang Z, Zhang Y.
    Zhonghua Fu Chan Ke Za Zhi; 2002 Feb 15; 37(2):86-9. PubMed ID: 11953071
    [Abstract] [Full Text] [Related]

  • 6. [Effect of long-term treatment with metformin on steroid levels and parameters of insulin resistance in women with polycystic ovary syndrome].
    Vrbíková J, Hill M, Stárka L, Cibula D, Snajderová M, Sulcová J, Vondra K, Bendlová B.
    Cas Lek Cesk; 2001 Nov 08; 140(22):688-94. PubMed ID: 11789058
    [Abstract] [Full Text] [Related]

  • 7. [Endocrine and metabolic effects of metformin in combination with compound cyproterone acetate in women with polycystic ovarian syndrome].
    Ye BL, Yang HY, Zhao JZ, Lin JJ, Lin WQ.
    Zhonghua Fu Chan Ke Za Zhi; 2003 Dec 08; 38(12):745-8. PubMed ID: 14728846
    [Abstract] [Full Text] [Related]

  • 8. [Metformin, an efficacious drug in the treatment of polycystic ovary syndrome].
    Hahn S, Quadbeck B, Elsenbruch S, Gärtner R, Finke R, Mann K, Janssen OE.
    Dtsch Med Wochenschr; 2004 May 07; 129(19):1059-64. PubMed ID: 15136950
    [Abstract] [Full Text] [Related]

  • 9. The effects of rosiglitazone and metformin on menstrual cyclicity and hirsutism in polycystic ovary syndrome.
    Yilmaz M, Karakoç A, Törüner FB, Cakir N, Tiras B, Ayvaz G, Arslan M.
    Gynecol Endocrinol; 2005 Sep 07; 21(3):154-60. PubMed ID: 16335907
    [Abstract] [Full Text] [Related]

  • 10. Two weeks of metformin improves clomiphene citrate-induced ovulation and metabolic profiles in women with polycystic ovary syndrome.
    Khorram O, Helliwell JP, Katz S, Bonpane CM, Jaramillo L.
    Fertil Steril; 2006 May 07; 85(5):1448-51. PubMed ID: 16579997
    [Abstract] [Full Text] [Related]

  • 11. The effect of metformin treatment for 2 years without caloric restriction on endocrine and metabolic parameters in women with polycystic ovary syndrome.
    Oppelt PG, Mueller A, Jentsch K, Kronawitter D, Reissmann C, Dittrich R, Beckmann MW, Cupisti S.
    Exp Clin Endocrinol Diabetes; 2010 Oct 07; 118(9):633-7. PubMed ID: 19998243
    [Abstract] [Full Text] [Related]

  • 12. Combined use of metformin and ethinyl estradiol-cyproterone acetate in polycystic ovary syndrome.
    Mitkov M, Pehlivanov B, Terzieva D.
    Eur J Obstet Gynecol Reprod Biol; 2005 Feb 01; 118(2):209-13. PubMed ID: 15653205
    [Abstract] [Full Text] [Related]

  • 13. Effects of metformin on clinical and biochemical parameters in polycystic ovary syndrome.
    Kriplani A, Agarwal N.
    J Reprod Med; 2004 May 01; 49(5):361-7. PubMed ID: 15214709
    [Abstract] [Full Text] [Related]

  • 14. Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity.
    Baillargeon JP, Jakubowicz DJ, Iuorno MJ, Jakubowicz S, Nestler JE.
    Fertil Steril; 2004 Oct 01; 82(4):893-902. PubMed ID: 15482765
    [Abstract] [Full Text] [Related]

  • 15. Metformin versus rosiglitazone in the treatment of polycystic ovary syndrome.
    Mitkov M, Pehlivanov B, Terzieva D.
    Eur J Obstet Gynecol Reprod Biol; 2006 May 01; 126(1):93-8. PubMed ID: 16360262
    [Abstract] [Full Text] [Related]

  • 16. Nonobese women with polycystic ovary syndrome respond better than obese women to treatment with metformin.
    Maciel GA, Soares Júnior JM, Alves da Motta EL, Abi Haidar M, de Lima GR, Baracat EC.
    Fertil Steril; 2004 Feb 01; 81(2):355-60. PubMed ID: 14967373
    [Abstract] [Full Text] [Related]

  • 17. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.
    Kazerooni T, Dehghan-Kooshkghazi M.
    Gynecol Endocrinol; 2003 Feb 01; 17(1):51-6. PubMed ID: 12724019
    [Abstract] [Full Text] [Related]

  • 18. Increased insulin-like growth factor-I levels in women with polycystic ovary syndrome, and beneficial effects of metformin therapy.
    Berker B, Emral R, Demirel C, Corapcioglu D, Unlu C, Kose K.
    Gynecol Endocrinol; 2004 Sep 01; 19(3):125-33. PubMed ID: 15697073
    [Abstract] [Full Text] [Related]

  • 19. The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome.
    Yilmaz M, Bukan N, Ayvaz G, Karakoç A, Törüner F, Cakir N, Arslan M.
    Hum Reprod; 2005 Dec 01; 20(12):3333-40. PubMed ID: 16123091
    [Abstract] [Full Text] [Related]

  • 20. Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia.
    Genazzani AD, Lanzoni C, Ricchieri F, Baraldi E, Casarosa E, Jasonni VM.
    Gynecol Endocrinol; 2007 Mar 01; 23(3):146-52. PubMed ID: 17454168
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.